Alaska 33rd Legislature (2023-2024) Status: In Committee 3 D cosponsors

SB 166 — An Act establishing the Alaska mental health and psychedelic medicine task force; and providing for an effective date.

Last action — (S) COSPONSOR(S): TOBIN

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 33rd Legislature (2023-2024). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Bill Text

What changed in the latest version

63 added · 68 removed

Plain-language change summary

The key change in SB 166 is that the task force will now be established within the Department of Commerce, Community, and Economic Development rather than as a legislative task force. This shift means that the task force will have a more direct connection to state agencies, potentially enabling quicker action on recommendations regarding mental health and psychedelic medicines. The purpose and responsibilities of the task force remain largely the same, focused on evaluating and preparing for the potential medical use of these substances in Alaska. This update is significant as it could streamline the process of addressing mental health needs using innovative treatments.

→
Previous
Latest
33-LS1062\P CS FOR SENATE BILL NO.
33-LS1062\S SENATE BILL NO.
166(L&C) IN THE LEGISLATURE OF THE STATE OF ALASKA THIRTY-THIRD LEGISLATURE - SECOND SESSION BY THE SENATE LABOR & COMMERCE COMMITTEE Referred:
166 IN THE LEGISLATURE OF THE STATE OF ALASKA THIRTY-THIRD LEGISLATURE - SECOND SESSION BY SENATORS DUNBAR, Gray-Jackson, Tobin Introduced:
Judiciary Sponsor(s):
1/16/24 Referred:
SENATORS DUNBAR, Gray-Jackson, Tobin A BILL FOR AN ACT ENTITLED "An Act establishing a legislative task force on mental health and psychedelic medicine;
Labor and Commerce, Judiciary A BILL FOR AN ACT ENTITLED "An Act establishing the Alaska mental health and psychedelic medicine task force;
(a) The Alaska mental health and psychedelic medicine task force is established as a task force of the Alaska State Legislature.
(a) The Alaska mental health and psychedelic medicine task force is established in the Department of Commerce, Community, and Economic Development.
The purpose of the task force is to prepare for the potential medicalization of psychedelic medicines by the United States Food and Drug Administration;
The purpose of the task force is to (1) assess the potential use of psychedelic medicine in addressing the state's ongoing mental health crisis;
to make policy recommendations to the Alaska State Legislature concerning insurance and licensure, given the unique nature of the administration of psychedelic medicines;
and to ensure the state is prepared if psychedelic medicines become available for prescription.
The task force shall (1) assess the potential use of psychedelic medicine in addressing the state's SB0166B -1- CSSB 166(L&C) New Text Underlined [DELETED TEXT BRACKETED] 33-LS1062\P ongoing mental health crisis;
(3) consider and recommend licensing and insurance requirements for practitioners in the state in the event that psychedelic medicines are federally reclassified and approved by the United States Food and Drug Administration;
(3) consider and recommend licensing and insurance requirements for practitioners in the state in the event that psychedelic medicines are federally reclassified and SB0166A -1- SB 166 New Text Underlined [DELETED TEXT BRACKETED] 33-LS1062\S approved by the United States Food and Drug Administration;
and (4) consider legal and regulatory changes that could be necessary in the state after federal medical approval of psychedelic medicines.
and (4) consider legal and regulatory pathways to the legalization of psychedelic medicines in the state, and the potential effects of the medicines on public health.
(5) two members representing the health care needs of Alaska Native communities, selected by the board of directors of the Alaska Native Health Board;
(5) two members representing the health care needs of Alaska Native communities, selected by the board of directors of the Alaska Native Health Board, one of whom must be a recognized indigenous ethnoherbalist;
(8) one member representing psychiatric nurse practitioners, selected by the board of directors of the Alaska Advanced Practice Registered Nurse Alliance;
(8) one member of the faculty of the division of population health sciences at the University of Alaska, selected by the president of the University of Alaska;
(9) one member representing licensed therapists or counselors, selected by the board of directors of the Alaska Addiction Professionals Association;
(9) one member of the senate appointed by the president of the senate;
(10) one member of the faculty of the division of population health sciences at the University of Alaska, selected by the president of the University of Alaska;
(10) one member of the house of representatives appointed by the speaker of the house of representatives;
(11) one member of the senate appointed by the president of the senate;
(11) up to three members selected by the task force, once assembled, that the task force determines would serve the purpose of the task force;
(12) one member of the house of representatives appointed by the speaker of the house of representatives;
CSSB 166(L&C) -2- SB0166B New Text Underlined [DELETED TEXT BRACKETED] 33-LS1062\P (13) up to three members selected by the task force, once assembled, that the task force determines would serve the purpose of the task force;
(e) Members of the task force serve without compensation.
(e) Members of the task force serve without compensation but are entitled to per diem SB 166 -2- SB0166A New Text Underlined [DELETED TEXT BRACKETED] 33-LS1062\S and travel expenses authorized for boards and commissions under AS 39.20.180.
and (2) on or before December 31, 2024, submit to the senate secretary, the chief clerk of the house of representatives, and the governor a report consisting of its recommendations, and notify the legislature that the report is available.
(2) ensure members are available for legislative hearings;
(g) The task force terminates when the First Regular Session of the Thirty-Forth Alaska State Legislature convenes.
and (3) on or before December 31, 2024, submit to the senate secretary, the chief clerk of the house of representatives, and the governor a report consisting of its recommendations, and notify the legislature that the report is available.
(g) The task force terminates when the First Regular Session of the Thirty-Fifth Alaska State Legislature convenes.
SB0166B -3- CSSB 166(L&C) New Text Underlined [DELETED TEXT BRACKETED]
SB0166A -3- SB 166 New Text Underlined [DELETED TEXT BRACKETED]
View plain text versions (3)

Action History

  1. (S) COSPONSOR(S): TOBIN

  2. (S) REFERRED TO RULES

  3. (S) FN1: ZERO(CED)

  4. (S) NR: KAUFMAN

  5. (S) DP: CLAMAN, GIESSEL, TOBIN, KIEHL

  6. (S) JUD RPT CS 4DP 1NR NEW TITLE

  7. (S) Moved CSSB 166(JUD) Out of Committee

  8. (S) JUDICIARY at 01:30 PM BUTROVICH 205

  9. (S) Minutes (SJUD)

  10. (S) Heard & Held

  11. (S) JUDICIARY at 01:30 PM BUTROVICH 205

  12. (S) FN1: ZERO(CED)

  13. (S) DP: DUNBAR, BISHOP

  14. (S) NR: BJORKMAN

  15. (S) L&C RPT CS 2DP 1NR NEW TITLE

  16. (S) Minutes (SL&C)

  17. (S) Moved CSSB 166(L&C) Out of Committee

  18. (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)

  19. (S) Minutes (SL&C)

  20. (S) Heard & Held

  21. (S) LABOR & COMMERCE at 01:30 PM BELTZ 105 (TSBldg)

  22. (S) COSPONSOR(S): GRAY-JACKSON

  23. (S) L&C, JUD

  24. (S) READ THE FIRST TIME - REFERRALS

  25. (S) Prefile released 1/8/24

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 62 not signed on

Sponsors (1)

Co-sponsors (2)

Not signed on (62)

62 members have not signed on to this bill.

Show all 62 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 166?
SB 166 is sponsored by Löki Tobin (D), Elvi Gray-Jackson (D), and Forrest Dunbar (D).
What is the current status of SB 166?
This bill died with 33rd Legislature (2023-2024). It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 166?
Track SB 166 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 166

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 166

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →